March 27, 2026

ACSM Revises Resistance Training Guidance

Synthesized evidence clarifies which training variables enhance strength, hypertrophy, and performance.

Conexiant

March 27, 2026

Airway Resistome Higher In Chronic Lung Disease

Recent antibiotic exposure was linked to greater antimicrobial resistance gene burden in bronchoscopy samples of patients with chronic lung disease.

Conexiant

March 26, 2026

Ultrasound Models Estimate Whole-Body Muscle Mass

New equations incorporating cross-sectional area improve estimation accuracy.

Conexiant

March 18, 2026

Medical Oddities: Friends, Family… and Faster Aging?

From gut gas trackers to bat vaccines, relationships and aging, GLP-1 hair shifts, and bug-based delivery—medicine keeps getting creative.

Conexiant

March 13, 2026

RSV Vaccine Eligibility Expands

Trial data show noninferior immune response in high-risk adults aged 18 to 49 years.

Conexiant

March 10, 2026

Not All COPD Is Smoking-Related

Study compares symptoms, spirometry, and inflammatory markers with smoking-related disease.

Conexiant

March 10, 2026

Singing Program Feasible After Pulmonary Rehabilitation

Study finds 12-week singing intervention feasible following pulmonary rehabilitation, supporting larger trial.

Conexiant

March 10, 2026

Psilocybin Beats Nicotine Patch in Smoking Trial

A single psilocybin dose outperforms standard nicotine replacement, opening a new front in one of medicine’s most intractable problems.

Conexiant

December 13, 2024

New Vaccine Prevents Severe RSV Illness

A recent study showed the new vaccine was more than 90% effective in the prevention of hospitalizations and emergency department visits due to RSV among those 60 years old or older.

Conexiant

November 13, 2024

Is COPD Set to Affect 600M Globally?

GOLD 2025 highlights new pathways and advanced COPD therapies like ensifentrine and dupilumab to reduce exacerbations and address emerging COPD phenotypes.

Conexiant